2786
S. Dallavalle et al. / Bioorg. Med. Chem. Lett. 18 (2008) 2781–2787
Figure 3. Structure of compound 16 in the ternary complex model. For the sake of clarity all the base pairs and only some amino acids are shown.
Tagliatatela, O., Eds.; Wiley-Vch: Weinheim, 2008; pp
503–520.
2. Wall, M. E.; Wani, M. C.; Cooke, C. E.; Palmer, K. T.;
McPhail, A. T.; Sim, G. A. J. Am. Chem. Soc. 1966, 88,
3888.
3. Hsiang, Y.-H.; Hertzberg, R.; Hecht, S. M.; Liu, L. F.
J. Biol. Chem. 1985, 260, 14873.
4. Liu, L. F.; Desai, S. D.; Li, T. K.; Mao, Y.; Sun, M.; Sim,
S. P.; Liehr, J. G.; Giovanella, B. C.; Verschraegen, C. F.
(Eds.) Ann. N.Y. Acad. Sci. 2000, 922, 1.
potency in the 7-substituted series (cfr. 1d vs 1c, 1g vs 1f
and 1l vs 1i).12 In the 9-substituted series a restoring ef-
fect of the methylation was observed for the 9-cyano
derivative (8b vs 4b), whereas in the case of 9-formyl-
CPT 5 and oxyiminoderivative 8a the drop of activity re-
mained. These results suggest that the presence of sub-
stituents in position 10 is detrimental for the activity
of 9-substituted CPT derivatives.
In conclusion, we have developed a synthetic method
suitable for a convenient preparation of 9-substituted
CPT derivatives using 9-formyl CPT as a versatile inter-
mediate. By means of this synthetic pathway we have
synthesized a series of novel camptothecins endowed
with potent cytotoxic activity. The results show that
the highest potency is obtained when a small polar, pos-
sibly H-acceptor group, is present in position 9.
5. Pommier, Y. Nat. Rev. Cancer 2006, 6, 789.
6. Thomas, C. J.; Rahier, N. J.; Hecht, S. M. Bioorg. Med.
Chem. 2004, 12, 1585.
7. Burke, T. G.; Mishra, A. K.; Wani, M. C.; Wall, M. E.
Biochemistry 1993, 32, 5352.
8. Staker, B. L.; Hjerrild, K.; Feese, M. D.; Behnke, C. A.;
Burgin, A. B., Jr.; Stewart, L. Proc. Natl. Acad. Sci.
U.S.A. 2002, 99, 15387.
9. Zunino, F.; Pratesi, G. Expert Opin. Invest. Drugs 2004,
13, 69.
10. Dallavalle, S.; Delsoldato, T.; Ferrari, A.; Merlini, L.;
Penco, S.; Carenini, N.; Perego, P.; De Cesare, M.; Pratesi,
G.; Zunino, F. J. Med. Chem. 2000, 43, 3963.
11. Dallavalle, S.; Ferrari, A.; Merlini, L.; Penco, S.; Carenini,
N.; Perego, P.; De Cesare, M.; Pratesi, G.; Zunino, F.
Bioorg. Med. Chem. Lett. 2001, 11, 291.
12. Dallavalle, S.; Ferrari, A.; Biasotti, B.; Merlini, L.; Penco,
S.; Gallo, G.; Marzi, M.; Tinti, M. O.; Martinelli, R.;
Pisano, C.; Carminati, P.; Carenini, N.; Beretta, G.;
Perego, P.; De Cesare, M.; Pratesi, G.; Zunino, F. J. Med.
Chem. 2001, 44, 3264.
Acknowledgments
We are indebted to Sigma-Tau, Pomezia and to Associ-
azione Italiana per la Ricerca sul Cancro, Milan, for
financial support.
Supplementary data
13. Sorbera, L. A.; Serradell, N.; Bolos, J.; Rosa, E.; Bozzo, J.
Drugs Future 2007, 32, 859.
Experimental: Synthesis and analytical data of com-
pounds and docking procedures. Supplementary data
associated with this article can be found, in the online
14. Huang, M.; Gao, H.; Chen, Y.; Zhu, H.; Cai, Y.; Zhang,
X.; Miao, Z.; Jiang, H.; Zhang, J.; Shen, H.; Lin, L.; Lu,
W.; Ding, J. Clin. Cancer Res. 2007, 13, 1298.
15. Kingsbury, W. D.; Boehm, J. C.; Jakas, D. R.; Holden, K.
G.; Hecht, S. M.; Gallagher, G.; Caranfa, M. J.; McCabe,
F. L.; Faucette, L. F.; Johnson, R. K.; Hertzberg, R. P.
J. Med. Chem. 1991, 34, 98.
References and notes
16. Gao, H.; Zhang, X.; Chen, Y.; Shen, H.; Sun, J.; Huang,
M.; Ding, J.; Li, C.; Lu, W. Bioorg. Med. Chem. Lett.
2005, 15, 2003.
1. (a) Du, W. Tetrahedron 2003, 59, 8649; (b) Dallavalle,
S.; Merlini, L. In Modern Alkaloids; Fattorusso, E.,